Use of a Lyophilized Reference Plasma to Compare Coagulation Test Procedures

Summary

In 4 collaborative trials, involving a varying number of hospital laboratories in the Stockholm area, the coagulation activity of different test materials was estimated with the one-stage prothrombin tests routinely used in the laboratories, viz. Normotest, Simplastin-A and Thrombotest. The test materials included different batches of a lyophilized reference plasma, deep-frozen specimens of diluted and undiluted normal plasmas, and fresh and deep-frozen specimens from patients on long-term oral anticoagulant therapy.

Although a close relationship was found between different methods, Simplastin-A gave consistently lower values than Normotest, the difference being proportional to the estimated activity. The discrepancy was of about the same magnitude on all the test materials, and was probably due to a divergence between the manufacturers’ procedures used to set “normal percentage activity”, as well as to a varying ratio of measured activity to plasma concentration. The extent of discrepancy may vary with the batch-to-batch variation of thromboplastin reagents.

The close agreement between results obtained on different test materials suggests that the investigated reference plasma could be used to calibrate the examined thromboplastin reagents, and to compare the degree of hypocoagulability estimated by the examined PIVKA-insensitive thromboplastin reagents.

The assigned coagulation activity of different batches of the reference plasma agreed closely with experimentally obtained values. The stability of supplied batches was satisfactory as judged from the reproducibility of repeated measurements. The variability of test procedures was approximately the same on different test materials.

• References

• 1 Bangham D. R, Biggs R, Brozović M, and Denson K. W. E. 1973; Calibration of five different thromboplastins, using fresh and freeze-dried plasma. Thrombosis et Diathesis Haemorrhagica 29: 228.
• 2 Biggs R, and Bangham D. R. 1971; Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations. British Medical Journal 3: 470.
• 3 Biggs R, and Denson K. W. E. 1967; Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. British Medical Journal 1: 84.
• 4 Denson K. W. E. 1971; International and national standardization of control of anticoagulant therapy in patients receiving coumarin and indanedione drugs using calibrated thromboplastin preparations. Journal of Clinical Pathology 24: 460.
• 5 Kahan J. 1974; Regional quality control of coagulation assay procedures (Normotest, Simplastin-A and Thrombotest). Thrombosis et Diathesis Haemorrhagica 32: 79.
• 6 Kahan J, and Nohen I. 1975; Assessment of different mathematical models for calculating and expressing the results of coagulation test procedures. Thrombosis et Diathesis Haemorrhagica 34: 522.
• 7 Koepke J. A. 1970; The 1969 survey of prothrombin time. American Journal of Clinical Pathology 54: 502.
• 8 Loeliger E. A. 1972; Progress in the control of oral anticoagulation. Thrombosis et Diathesis Haemorrhagica 28: 109.
• 9 Loeliger E. A, Meuwisse-Braun J. B, Muis H, Buitendijk F. J. J, Veltkamp J. J, and Hemker H. C. 1970; Laboratory control of oral anticoagulants. Thrombosis et Diathesis Haemorrhagica 23: 569.
• 10 Miale J. B, and Lafond D. J. 1967; 1963 prothrombin time test survey, College of American Pathologists, Standards Committee, Subcommittee on Coagulation. American Journal of Clinical Pathology 47: 40.
• 11 Miale J. B, and Lafond D. J. 1969; Prothrombin time standardization. American Journal of Clinical Pathology 52: 154.
• 12 Miale J. B, and Kent J. W. 1972; Standardization of the therapeutic range for oral anticoagulants based on standard reference plasmas. American Journal of Clinical Pathology 157: 80.
• 13 Miale J. B, and Kent J. W. 1973; Performance characteristics of reference thromboplastins. American Journal of Clinical Pathology 60: 453.
• 14 Poller L. 1967; A national standard for anticoagulant therapy. The Manchester Comparative Reagent. Lancet I: 491.